Predictive value of immune genes related to RAS/KIT mutations in the response of TGCT to cisplatin-based chemotherapy and immunotherapy

被引：0
|
作者：
Song, N. [1 ]
Ji, C. [1 ]
机构：
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0043
引用
收藏
页码：S732 / S732
页数：1
相关论文
共 38 条
  • [31] Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy
    Jessen, Christian
    Agerbaek, Mads
    Von Der Maase, Hans
    ACTA ONCOLOGICA, 2009, 48 (03) : 411 - 417
  • [32] Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314.
    Iyer, Gopa
    Tangen, Catherine
    Sarfaty, Michal
    Regazzi, Ashley Marie
    Lee, I-Ling C.
    Choi, Woonyoung
    Dinney, Colin P. N.
    Flaig, Thomas W.
    Thompson, Ian M.
    McConkey, David James
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Prognostic value of class III b-tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin-based chemotherapy (CT): A validation study on three randomized trials
    Reiman, T.
    Seve, P.
    Vataire, A.
    Dunant, A.
    Rosell, R.
    Graziano, S.
    Seymour, L.
    Pirker, R.
    Lai, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
    Feng, Wentao
    Zuo, Mingrong
    Li, Wenhao
    Chen, Siliang
    Wang, Zhihao
    Yuan, Yunbo
    Yang, Yuan
    Liu, Yanhui
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Predictive value of DNA repair gene alterations for the response to platinum-based chemotherapy and immunotherapy in advanced solid tumors patients: Results from a single center molecular screening program
    Chabot, C.
    Cousin, S.
    Khalifa, E.
    Ceruso, M. Spalato
    Soubeyran, I.
    Laizet, Y.
    Crombe, A.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1324 - S1324
  • [36] Germline and somatic mutations in 25 hereditary breast and ovarian cancer related genes and platinum-based chemotherapy response among Chinese patients with epithelial ovarian cancer.
    Li, Lei
    Wu, Ming
    Zhu, Changbin
    Shao, Di
    Liu, Meng
    Xiehe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] ERCC1 immunohistochemical expression is related to histological differentiation and predicts objective response and disease-free survival in patients treated by cisplatin-based chemotherapy for locally advanced head and neck squamous-cell carcinoma
    Handra-Luca, Adriana
    Hernandez, Juana
    Mountzios, Giannis
    Taranchon, Estelle
    Lacau-St-Guily, Jean
    Soria, Jean-Charles
    Fouret, Pierre
    VIRCHOWS ARCHIV, 2007, 451 (02) : 461 - 461
  • [38] Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study
    Lee, Dong Hyeon
    Jeong, Jae Yong
    Song, Wan
    ONCOTARGETS AND THERAPY, 2021, 14 : 845 - 855
1234